Literature DB >> 29414603

A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing.

Ruoji Zhou1, An Xu2, Donghui Wang3, Dandan Zhu2, Helen Mata4, Zijun Huo5, Jian Tu6, Mo Liu2, Alaa M T Mohamed2, Brittany E Jewell1, Julian Gingold7, Weiya Xia8, Pulivarthi H Rao4, Mien-Chie Hung9, Ruiying Zhao10, Dung-Fang Lee11.   

Abstract

The tumor suppressor gene TP53 is the most frequently mutated gene in human cancers. Many hot-spot mutations of TP53 confer novel functions not found in wild-type p53 and contribute to tumor development and progression. We report on the generation of a H1 human embryonic stem cell line carrying a homozygous TP53 R282W mutation using TALEN-mediated genome editing. The generated cell line demonstrates normal karyotype, maintains a pluripotent state, and is capable of generating a teratoma in vivo containing tissues from all three germ layers.
Copyright © 2018 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29414603     DOI: 10.1016/j.scr.2018.01.035

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  4 in total

1.  Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells.

Authors:  Ruoji Zhou; An Xu; Jian Tu; Mo Liu; Julian A Gingold; Ruiying Zhao; Dung-Fang Lee
Journal:  J Vis Exp       Date:  2018-06-13       Impact factor: 1.355

Review 2.  Cancer in a dish: progress using stem cells as a platform for cancer research.

Authors:  Mo Liu; Jian Tu; Julian A Gingold; Celine Shuet Lin Kong; Dung-Fang Lee
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

3.  Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing.

Authors:  An Xu; Ruoji Zhou; Jian Tu; Zijun Huo; Dandan Zhu; Donghui Wang; Julian A Gingold; Helen Mata; Pulivarthi H Rao; Mo Liu; Alaa M T Mohamed; Celine Shuet Lin Kong; Brittany E Jewell; Weiya Xia; Ruiying Zhao; Mien-Chie Hung; Dung-Fang Lee
Journal:  Stem Cell Res       Date:  2018-04-27       Impact factor: 2.020

4.  Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.

Authors:  Mei Song; Oladapo O Yeku; Sarwish Rafiq; Terence Purdon; Xue Dong; Lijing Zhu; Tuo Zhang; Huan Wang; Ziqi Yu; Junhua Mai; Haifa Shen; Briana Nixon; Ming Li; Renier J Brentjens; Xiaojing Ma
Journal:  Nat Commun       Date:  2020-12-08       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.